Tenax Therapeutics, Inc.
Tenax Therapeutics, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-Term Open-Label Extension Study of Oral Levosimendan | cardiovascular disorder, heart disorder, heart failure | Enrolling by invitation | Phase 3 | 2026-09-09 | NCT07436689 | |
| LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-08-19 | NCT07288398 | |
| LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF | cardiovascular disorder, heart disorder, heart failure, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-07-24 | NCT05983250 |